Flow Cytometry in Acute Leukemia: From Diagnosis to Disease Monitoring
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 2
Special Issue Editors
Interests: leukemia; immunophenotype; flow cyometry
Special Issue Information
Dear Colleagues,
Flow cytometry plays a crucial role in the management of acute leukemia, from initial diagnosis to treatment monitoring. It enables rapid and precise identification of leukemic cell populations based on their immunophenotypic profiles, helping distinguish between different subtypes of acute lymphoblastic and myeloid leukemias. Beyond diagnosis, flow cytometry is essential for detecting minimal/measurable residual disease (MRD), allowing clinicians to assess treatment response, predict relapse risk, and guide therapeutic decisions. Advances in multiparametric and high-dimensional flow cytometry enable high levels of sensitivity and standardization, as well as the conduct of studies on leukemic stem cells (LSCs), making it an indispensable tool in modern leukemia diagnostics and patient follow-up.
Recent advances include the implementation of Next-Generation Flow (NGF) approaches, which combine high-dimensional data acquisition with automated analysis algorithms to improve accuracy, reproducibility, and inter-laboratory harmonization. Integration with multi-omics strategies, which link flow cytometric data with genomic and transcriptomic profiling, is enhancing disease characterization and therapeutic decision-making. These innovations are transforming flow cytometry from a primarily diagnostic technique into a dynamic platform for precision disease monitoring and individualized patient management in acute leukemia.
Prof. Dr. Donatella Raspadori
Dr. Paola Pacelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute leukemia
- ALL
- AML
- flow cytometry
- NGF
- leukemia stem cells (LSCs
- minimal residual disease (MRD)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
